The Feces Category

Interest in fecal transplants as a way to replace gut microflora to treat recurrent Clostridium difficile infections has been piqued in recent years, and a study published in the New England Journal of Medicine about a year ago showed that fecal microbiota transplants were more effective than vancomycin therapy for treating recurrent C. difficile infections

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Don't Chew The Pills!

What's Healthy?

This Week in PLOS

This Week in Nature

Balanced Diet

This Week in Cell

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.